196 related articles for article (PubMed ID: 16616784)
1. Novel isoforms of NADPH-oxidase in cerebral vascular control.
Miller AA; Drummond GR; Sobey CG
Pharmacol Ther; 2006 Sep; 111(3):928-48. PubMed ID: 16616784
[TBL] [Abstract][Full Text] [Related]
2. NADPH oxidase activity and function are profoundly greater in cerebral versus systemic arteries.
Miller AA; Drummond GR; Schmidt HH; Sobey CG
Circ Res; 2005 Nov; 97(10):1055-62. PubMed ID: 16210546
[TBL] [Abstract][Full Text] [Related]
3. NADPH-oxidase activity is elevated in penumbral and non-ischemic cerebral arteries following stroke.
Miller AA; Dusting GJ; Roulston CL; Sobey CG
Brain Res; 2006 Sep; 1111(1):111-6. PubMed ID: 16879806
[TBL] [Abstract][Full Text] [Related]
4. NADPH oxidases, reactive oxygen species, and hypertension: clinical implications and therapeutic possibilities.
Paravicini TM; Touyz RM
Diabetes Care; 2008 Feb; 31 Suppl 2():S170-80. PubMed ID: 18227481
[TBL] [Abstract][Full Text] [Related]
5. NADPH oxidase and endothelial cell function.
Ray R; Shah AM
Clin Sci (Lond); 2005 Sep; 109(3):217-26. PubMed ID: 16104842
[TBL] [Abstract][Full Text] [Related]
6. Nox4 as the major catalytic component of an endothelial NAD(P)H oxidase.
Ago T; Kitazono T; Ooboshi H; Iyama T; Han YH; Takada J; Wakisaka M; Ibayashi S; Utsumi H; Iida M
Circulation; 2004 Jan; 109(2):227-33. PubMed ID: 14718399
[TBL] [Abstract][Full Text] [Related]
7. Distinct role of nox1, nox2, and p47phox in unstimulated versus angiotensin II-induced NADPH oxidase activity in human venous smooth muscle cells.
Chose O; Sansilvestri-Morel P; Badier-Commander C; Bernhardt F; Fabiani JN; Rupin A; Verbeuren TJ
J Cardiovasc Pharmacol; 2008 Feb; 51(2):131-9. PubMed ID: 18287880
[TBL] [Abstract][Full Text] [Related]
8. Localizing NADPH oxidase-derived ROS.
Ushio-Fukai M
Sci STKE; 2006 Aug; 2006(349):re8. PubMed ID: 16926363
[TBL] [Abstract][Full Text] [Related]
9. Selective targeting of NADPH oxidase for cardiovascular protection.
Cave A
Curr Opin Pharmacol; 2009 Apr; 9(2):208-13. PubMed ID: 18973829
[TBL] [Abstract][Full Text] [Related]
10. Vascular dysfunction in cerebrovascular disease: mechanisms and therapeutic intervention.
Miller AA; Budzyn K; Sobey CG
Clin Sci (Lond); 2010 Apr; 119(1):1-17. PubMed ID: 20370718
[TBL] [Abstract][Full Text] [Related]
11. Increased NADPH-oxidase activity and Nox4 expression during chronic hypertension is associated with enhanced cerebral vasodilatation to NADPH in vivo.
Paravicini TM; Chrissobolis S; Drummond GR; Sobey CG
Stroke; 2004 Feb; 35(2):584-9. PubMed ID: 14739416
[TBL] [Abstract][Full Text] [Related]
12. Reactive oxygen species in the cerebral circulation: are they all bad?
Miller AA; Drummond GR; Sobey CG
Antioxid Redox Signal; 2006; 8(7-8):1113-20. PubMed ID: 16910759
[TBL] [Abstract][Full Text] [Related]
13. A role for NOX NADPH oxidases in Alzheimer's disease and other types of dementia?
Zekry D; Epperson TK; Krause KH
IUBMB Life; 2003 Jun; 55(6):307-13. PubMed ID: 12938732
[TBL] [Abstract][Full Text] [Related]
14. Redox signaling in angiogenesis: role of NADPH oxidase.
Ushio-Fukai M
Cardiovasc Res; 2006 Jul; 71(2):226-35. PubMed ID: 16781692
[TBL] [Abstract][Full Text] [Related]
15. Suppression of oxidative stress in the endothelium and vascular wall.
Jiang F; Drummond GR; Dusting GJ
Endothelium; 2004; 11(2):79-88. PubMed ID: 15370067
[TBL] [Abstract][Full Text] [Related]
16. Molecular mechanisms of hypertension: role of Nox family NADPH oxidases.
Sedeek M; Hébert RL; Kennedy CR; Burns KD; Touyz RM
Curr Opin Nephrol Hypertens; 2009 Mar; 18(2):122-7. PubMed ID: 19430333
[TBL] [Abstract][Full Text] [Related]
17. Composition and functions of vascular nicotinamide adenine dinucleotide phosphate oxidases.
Brandes RP; Schröder K
Trends Cardiovasc Med; 2008 Jan; 18(1):15-9. PubMed ID: 18206804
[TBL] [Abstract][Full Text] [Related]
18. Nox4 mediates the expression of plasminogen activator inhibitor-1 via p38 MAPK pathway in cultured human endothelial cells.
Jaulmes A; Sansilvestri-Morel P; Rolland-Valognes G; Bernhardt F; Gaertner R; Lockhart BP; Cordi A; Wierzbicki M; Rupin A; Verbeuren TJ
Thromb Res; 2009 Sep; 124(4):439-46. PubMed ID: 19540572
[TBL] [Abstract][Full Text] [Related]
19. Reactive oxygen species and vascular biology: implications in human hypertension.
Touyz RM; Briones AM
Hypertens Res; 2011 Jan; 34(1):5-14. PubMed ID: 20981034
[TBL] [Abstract][Full Text] [Related]
20. Aldosterone nongenomically produces NADPH oxidase-dependent reactive oxygen species and induces myocyte apoptosis.
Hayashi H; Kobara M; Abe M; Tanaka N; Gouda E; Toba H; Yamada H; Tatsumi T; Nakata T; Matsubara H
Hypertens Res; 2008 Feb; 31(2):363-75. PubMed ID: 18360057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
